Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?
The FDA has issued a warning to a major compounding pharmacy for producing excessive amounts of weight-loss drug copies. The action raises concerns about the future availability of cheaper GLP-1 alternatives.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
READ NEXT
More on the wire
AI TLDR
New Jersey Governor Sherrill is demanding the resignation of Lieutenant Governor Dale Caldwell following a sexual harassment investigation. The probe revealed Caldwell made inappropriate comments and attempted to improperly influence personnel decisions.
AI TLDR
Donald Trump and House Speaker Mike Johnson are expected to meet with artificial intelligence company CEOs next week to discuss the industry.
AI TLDR
The administration is petitioning the Supreme Court to allow the swift deportation of immigrants to third countries rather than their countries of origin.